Compare Kimberly Clark Corp (KMB) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimberly Clark Corp vs 10X Genomics Inc — how do they compare? Kimberly Clark Corp trades at $108.57 (market cap $36.11B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: Kimberly Clark Corp is far larger — about 4.7× 10X Genomics Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| KMB | TXG | |
|---|---|---|
Market Cap | $36.11B | $7.61B |
Sector | Consumer Staples | Health |
52-Week High | $134.81 | $58.57 |
52-Week Low | $93.05 | $11.34 |
Enterprise Value | $41.67B | $7.14B |
Dividend Yield | 4.72% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
